Cullinan Therapeutics, Inc. (CGEM)
NASDAQ · Healthcare
Cullinan Therapeutics, Inc. Cash on Hand 2020–2022
Cullinan Therapeutics, Inc. annual cash on hand history from 2020 to 2022. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Cullinan Therapeutics, Inc. cash on hand as of December 31, 2022: 156.2M, a 161.24% increase year-over-year.
- Cullinan Therapeutics, Inc. cash on hand for 2022 were 156.2M, a 161.24% increase from 2021.
- Cullinan Therapeutics, Inc. cash on hand for 2021 were 59.8M, a 64.46% decrease from 2020.
- Cullinan Therapeutics, Inc. cash on hand for 2020 were 168.2M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Cullinan Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2022 | $156 |
| 2021 | $60 |
| 2020 | $168 |
Cullinan Therapeutics, Inc. Cash on Hand — FAQ
Cullinan Therapeutics, Inc. (CGEM) cash on hand over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CGEM's cash on hand history?
The chart and table above show Cullinan Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.